| RS33971440 |
HBB
|
Health Risk |
Pathogenic |
Beta zero thalassemia, beta Thalassemia |
| RS33971634 |
HBB
|
Health Risk |
Pathogenic |
Dominant beta-thalassemia, Dominant beta-thalassemia |
| RS33972047 |
HBB
|
Health Risk |
Pathogenic |
HEMOGLOBIN MALAY, BETA-PLUS-THALASSEMIA |
| RS33972593 |
HBB
|
Health Risk |
Likely pathogenic |
HEMOGLOBIN BRISBANE, HEMOGLOBIN GREAT LAKES |
| RS33974936 |
HBB
|
Health Risk |
Pathogenic |
Beta zero thalassemia, beta Thalassemia |
| RS33975915 |
SLC5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital glucose-galactose malabsorption, Inborn genetic diseases |
| RS33977363 |
HBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
HEMOGLOBIN WINNIPEG, HEMOGLOBIN WINNIPEG |
| RS33978134 |
HBA1
|
Health Risk |
Likely pathogenic |
HEMOGLOBIN MILLEDGEVILLE, Erythrocytosis |
| RS33978338 |
HBB
|
Health Risk |
Likely pathogenic |
HEMOGLOBIN CHEVERLY, HEMOGLOBIN ARTA |
| RS33978901 |
VWF
|
Health Risk |
Conflicting classifications of pathogenicity |
von Willebrand disease type 2, von Willebrand disease type 1 |
| RS33978907 |
HBB
|
Health Risk |
Pathogenic |
BETA-PLUS-THALASSEMIA, BETA-PLUS-THALASSEMIA |
| RS33979901 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS33980857 |
HBB
|
Health Risk |
Pathogenic |
BETA-PLUS-THALASSEMIA, beta Thalassemia |
| RS33981098 |
HBB
|
Health Risk |
Pathogenic |
BETA-PLUS-THALASSEMIA, beta Thalassemia |
| RS33981325 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12 |
| RS33982568 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
Beta zero thalassemia, beta Thalassemia |
| RS33983205 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
HEMOGLOBIN DEER LODGE, HEMOGLOBIN DEER LODGE |
| RS33983276 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
HEMOGLOBIN KHARTOUM, Hemoglobinopathy |
| RS33983416 |
HBA2
|
Health Risk |
Pathogenic; other |
HEMOGLOBIN COLUMBIA MISSOURI, Erythrocytosis |
| RS33985472 |
HBB
|
Health Risk |
Pathogenic |
BETA-PLUS-THALASSEMIA, beta Thalassemia |
| RS33985544 |
HBB
|
Health Risk |
Likely pathogenic |
HEMOGLOBIN ZURICH, Hemoglobinopathy |
| RS33985574 |
HBA2
|
Health Risk |
Pathogenic; other |
HEMOGLOBIN J (BUDA), Erythrocytosis |
| RS33986703 |
HBB
|
Health Risk |
Pathogenic |
Beta zero thalassemia, beta Thalassemia |
| RS33987053 |
HBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
alpha Thalassemia, alpha Thalassemia |
| RS33987903 |
HBB
|
Health Risk |
Pathogenic; other |
HEMOGLOBIN HELSINKI, Erythrocytosis |
| RS33987957 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
HEMOGLOBIN BEOGRAD, HEMOGLOBIN D (CAMPERDOWN) |
| RS33991059 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS33991294 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
HEMOGLOBIN J (IRAN), HEMOGLOBIN J (IRAN) |
| RS33991779 |
HBA1
|
Health Risk |
Pathogenic; other |
HEMOGLOBIN CHESAPEAKE, Erythrocytosis |
| RS33991910 |
HBA1
|
Health Risk |
Pathogenic; other |
HEMOGLOBIN NUNOBIKI, Erythrocytosis |
| RS33991993 |
HBB
|
Health Risk |
Likely pathogenic |
HEMOGLOBIN PROVIDENCE, Erythrocytosis |
| RS33993004 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
HEMOGLOBIN VILA REAL, Erythrocytosis |
| RS33993166 |
HBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
HEMOGLOBIN O (PADOVA), HEMOGLOBIN O (PADOVA) |
| RS33993568 |
HBB
|
Health Risk |
Likely pathogenic |
HEMOGLOBIN D (IBADAN), beta Thalassemia |
| RS33994806 |
HBB
|
Health Risk |
Likely pathogenic |
BETA-PLUS-THALASSEMIA, beta Thalassemia |
| RS33995148 |
HBB
|
Health Risk |
Pathogenic |
Beta zero thalassemia, beta Thalassemia |
| RS33995463 |
LRRK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Parkinson disease 8, Autosomal dominant Parkinson disease 8 |
| RS33997263 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS33998064 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS33999427 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
HEMOGLOBIN TAK, Hemoglobinopathy |
| RS34000044 |
C9
|
Health Risk |
Pathogenic/Likely pathogenic |
Complement component 9 deficiency, Age related macular degeneration 15 |
| RS34000644 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia, autosomal recessive |
| RS34002892 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS34003473 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, PTEN hamartoma tumor syndrome |
| RS34004222 |
COL4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome, Optic nerve hypoplasia |
| RS34004854 |
MRTFA
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34008139 |
MAP3K6
|
Health Risk |
Likely pathogenic |
— |
| RS34013622 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
Erythrocytosis, familial |
| RS34014629 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS34016629 |
FREM2
|
Health Risk |
Pathogenic |
— |
| RS34018205 |
ATP8B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 1, ATP8B1-related disorder |
| RS34019119 |
AGA
|
Health Risk |
Conflicting classifications of pathogenicity |
Aspartylglucosaminuria, Inborn genetic diseases |
| RS34019455 |
G6PC3
|
Health Risk |
Pathogenic |
Inherited Immunodeficiency Diseases, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS34021271 |
HBA1
|
Health Risk |
Pathogenic |
alpha Thalassemia, alpha Thalassemia |
| RS34028295 |
COX14
|
Health Risk |
Likely pathogenic |
— |
| RS34029285 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS34029390 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
beta Thalassemia, HBB-related disorder |
| RS34030828 |
PNPLA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia |
| RS34034503 |
LY75
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34035085 |
UPB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of beta-ureidopropionase, Deficiency of beta-ureidopropionase |
| RS34036746 |
ARHGEF10
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant slowed nerve conduction velocity, Gastric cancer |
| RS34040119 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS34041086 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
LRP2-related disorder, LRP2-related disorder |
| RS34043251 |
FN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chronic kidney disease, Glomerulopathy with fibronectin deposits 2 |
| RS34044042 |
RBP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS34044544 |
SLC34A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatemic nephrolithiasis/osteoporosis 1, Fanconi renotubular syndrome 2 |
| RS34049451 |
RD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 12, Leber congenital amaurosis 12 |
| RS34050897 |
SARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperuricemia, pulmonary hypertension |
| RS34051360 |
LTBP4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34052957 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
LRP2-related disorder, LRP2-related disorder |
| RS34055850 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Otospondylomegaepiphyseal dysplasia, autosomal recessive |
| RS34057094 |
CLCF1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34061568 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS34065266 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS34069565 |
REN
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular dysgenesis, Familial juvenile hyperuricemic nephropathy type 2 |
| RS34071195 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Alstrom syndrome |
| RS34071623 |
TRPV4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2C, Neuronopathy |
| RS34072093 |
MERTK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS34074602 |
LRP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34075659 |
REC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Non-obstructive azoospermia, Melanoma |
| RS34079299 |
IFNG
|
Health Risk |
risk factor |
Aplastic anemia, susceptibility to |
| RS34081806 |
RAB3GAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Warburg micro syndrome 2, Martsolf syndrome |
| RS34082669 |
CANT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Desbuquois dysplasia 1, CANT1-related disorder |
| RS34082929 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Hereditary spastic paraplegia 15 |
| RS34083085 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS34083951 |
HBB
|
Health Risk |
Likely pathogenic |
HEMOGLOBIN SAINT ETIENNE, Beta-thalassemia HBB/LCRB |
| RS34084741 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, Wiskott-Aldrich syndrome |
| RS34084984 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS34089426 |
AP3B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS34091239 |
RAD51
|
Health Risk |
Pathogenic |
Mirror movements 2, Mirror movements 2 |
| RS34092089 |
MKS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS34094720 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS34096980 |
PYGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type VI |
| RS34097903 |
PADI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Central centrifugal cicatricial alopecia, Central centrifugal cicatricial alopecia |
| RS34098449 |
HBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34099398 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS34100397 |
GAD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities |
| RS34102501 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Duchenne muscular dystrophy |
| RS34103564 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Hereditary cancer-predisposing syndrome |
| RS34116584 |
AGXT
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type I |